Ledger.Open graph →
SEC Form D · Amendment · filed January 6, 2021

Zyus Life Sciences Inc

Offering
$19.2M
Sold
$15.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SASKATOON, Saskatchewan, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Brent Zettl · Saskatoon, Saskatchewan, CanadaExec · DirectorRichard Hoyt · Saskatoon, Saskatchewan, CanadaDirectorRob Harding · Saskatoon, Saskatchewan, CanadaExecKeith Carpenter · Saskatoon, Saskatchewan, CanadaExecDonald Ching · Saskatoon, Saskatchewan, CanadaDirectorLarry Holbrook · Saskatoon, Saskatchewan, CanadaExecJohn Knowles · Saskatoon, Saskatchewan, CanadaDirectorMichelle Gursky · Saskatoon, Saskatchewan, CanadaExecIok W. Pang · Warwick, RIDirectorPing W. Chang · Warwick, RIDirectorJodi W. Brichan · Warwick, RIExecRobert Kupper · Warwick, RIExecPaul Ferris · South San Francisco, CAExec · DirectorDaniel Goodman · HOUSTON, TXExecJohn Noonan · CHEVY CHASE, MDExecLex W. Adjei · Warwick, RIDirectorPaul Freeman · Grand Cayman, Cayman IslandsExec · DirectorDesmond Murray · Grand Cayman, Cayman IslandsExecWilliam Roberts · Grand Cayman, Cayman IslandsExecAndrew Byington · NEW YORK, NYExecGus R. Rossi · New York, NYDirectorSimcoe Management Company, LLC · New York, NYDirectorRussell W. Norwood · Austin, TXDirectorPeter Siegel · Asbury Park, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗